Cancer Management and Research (May 2022)

Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment [Corrigendum]

  • Tong III J,
  • Mao Y,
  • Yang Z,
  • Xu Q,
  • Zheng Z,
  • Zhang H,
  • Wang J,
  • Zhang S,
  • Rong W,
  • Zheng III L

Journal volume & issue
Vol. Volume 14
pp. 1653 – 1654

Abstract

Read online

Tong III J, Mao Y, Yang Z, et al. Cancer Manag Res. 2021;13:4041–4053. The authors have advised due to an error at the time of figure assembly, Figure 2D on page 4048 is incorrect. The correct Figure 2 is shown in Download Article:   The authors apologize for this error and advise it does not affect the results of the paper. Read the original article